N
Nicoletta Masera
Researcher at University of Milan
Publications - 38
Citations - 661
Nicoletta Masera is an academic researcher from University of Milan. The author has contributed to research in topics: Population & Acute chest syndrome. The author has an hindex of 12, co-authored 35 publications receiving 494 citations. Previous affiliations of Nicoletta Masera include University of Milano-Bicocca.
Papers
More filters
Journal ArticleDOI
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia.
Sarah Marktel,Samantha Scaramuzza,Maria Pia Cicalese,Fabio Giglio,Stefania Galimberti,Maria Rosa Lidonnici,Valeria Calbi,Andrea Assanelli,Maria Ester Bernardo,Claudia Rossi,Andrea Calabria,Raffaella Milani,Salvatore Gattillo,Fabrizio Benedicenti,Giulio Spinozzi,Annamaria Aprile,Alessandra Bergami,Miriam Casiraghi,Giulia Consiglieri,Nicoletta Masera,Emanuela D'Angelo,Nadia Mirra,Raffaella Origa,Immacolata Tartaglione,Silverio Perrotta,Robert Winter,Milena Coppola,Gianluca Viarengo,Luca Santoleri,Giovanna Graziadei,Michela Gabaldo,Maria Grazia Valsecchi,Eugenio Montini,Luigi Naldini,Maria Domenica Cappellini,Fabio Ciceri,Alessandro Aiuti,Giuliana Ferrari +37 more
TL;DR: In a phase 1/2 clinical trial, gene therapy with autologous hematopoietic stem cells significantly reduced transfusion requirement in adults and children with transfusion dependent ß-thalassemia.
Journal ArticleDOI
Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Silvia Einaudi,Nicoletta Bertorello,Nicoletta Masera,L. Farinasso,Elena Barisone,Carmelo Rizzari,Andrea Corrias,Alessia Villa,Francesca Riva,Paola Saracco,Guido Pastore +10 more
TL;DR: High‐dose glucocorticoid therapy in ALL children may cause prolonged adrenal suppression and related clinical symptoms and laboratory monitoring of cortisol levels and steroid coverage during stress episodes may be indicated.
Journal ArticleDOI
Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy.
Nicoletta Masera,Luisa Tavecchia,Marietta Capra,Giovanni Cazzaniga,C. Vimercati,Lorena Pozzi,Andrea Biondi,Giuseppe Masera +7 more
TL;DR: The case of a young girl with β-thalassaemia (β+/β°) in a very severe clinical condition who could not be given any further transfusions because of the occurrence of severe post-transfusion reactions is reported and who showed an outstanding response to thalidomide.
Journal ArticleDOI
Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent
Paolo Rigano,Lucia De Franceschi,Laura Sainati,Antonio Piga,Frédéric B. Piel,Maria Domenica Cappellini,Carmelo Fidone,Nicoletta Masera,Giovanni Palazzi,Barbara Gianesin,Gian Luca Forni +10 more
TL;DR: A large population of patients with different descent and compound state supports the benefits of hydroxyurea therapy as a treatment option, and there were no new safety concerns observed compared to those commonly reported in the literature.
Journal ArticleDOI
Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian Association.
Saverio Ladogana,Matteo Maruzzi,Piera Samperi,Silverio Perrotta,Giovanni Carlo Del Vecchio,Lucia Dora Notarangelo,Piero Farruggia,Federico Verzegnassi,Nicoletta Masera,Paola Saracco,Silvia Fasoli,Maurizio Miano,Gabriella Girelli,Wilma Barcellini,Alberto Zanella,Giovanna Russo +15 more
TL;DR: Recommendations for treatment include: dosage of steroid therapy and tapering modality for warm autoimmune haemolytic anaemia; the choice of rituximab as first-line therapy for the rare primary transfusion-dependent cold autoimmune Haemolytics anaemia.